HomeSRT3 • ETR
Sartorius AG Preference Shares
Follow
In the news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2023info | Y/Y change |
|---|---|---|
Revenue | 832.00M | -19.66% |
Operating expense | 281.30M | 9.16% |
Net income | 95.00M | -42.70% |
Net profit margin | 11.42 | -28.67% |
Earnings per share | 1.26 | -48.36% |
EBITDA | 203.50M | -40.51% |
Effective tax rate | 16.72% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 162.20M | -30.42% |
Total assets | 7.04B | 12.73% |
Total liabilities | 4.34B | 8.19% |
Total equity | 2.71B | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | 4.48% | — |
Return on capital | 5.90% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2023info | Y/Y change |
|---|---|---|
Net income | 95.00M | -42.70% |
Cash from operations | 160.20M | 64.65% |
Cash from investing | -189.30M | -45.28% |
Cash from financing | 30.10M | 267.07% |
Net change in cash | 10.00M | 171.94% |
Free cash flow | -177.82M | -194.78% |
Previous close
€352.70
Day range
€350.90 - €356.10
Year range
€291.90 - €471.70
Market cap
23.94B EUR
Avg Volume
79.98K
P/E ratio
49.05
Dividend yield
0.40%
About
Sartorius AG is an international pharmaceutical and laboratory equipment supplier, covering the segments of Bioprocess Solutions and Lab Products & Services. Wikipedia
Founded
1870
Website
Employees
15,048
